Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity

Journal of Psychopharmacology

Volumn 28, Issue 9, 2014, Pages 866-873

  Van De Giessen, Elsmarieke ^a   Celik, Funda ^b   Schweitzer, Dave H ^c   Van Den Brink, Wim ^a   Booij, Jan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

dexamphetamine; dopamine D2 3 receptor; dopamine release; Obesity; single photon emission computed tomography; striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IODOBENZAMIDE I 131; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DRD2 PROTEIN, HUMAN; IDOBENZAMIDE; IODOBENZENE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOPAMINE RELEASE; FEEDING BEHAVIOR; FEMALE; GENERAL FOOD CRAVING QUESTIONNAIRE TRAIT; HUMAN; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; PRIORITY JOURNAL; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; YOUNG ADULT; ADOLESCENT; CONTROLLED CLINICAL TRIAL; CORPUS STRIATUM; DIAGNOSTIC USE; DRUG EFFECTS; FUNCTIONAL NEUROIMAGING; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AMPHETAMINE; CORPUS STRIATUM; CRAVING; DOPAMINE; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; IODOBENZENES; MIDDLE AGED; OBESITY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84906057950     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114531664     Document Type: Article

References (41)

1. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev. 2008 ; 32: 20-39
2. Booij J, Korn P, Linszen DH, et al. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography. Eur J Nucl Med. 1997 ; 24: 674-677
3. Boot E, Booij J, Hasler G, et al. AMPT-induced monoamine depletion in humans: Evaluation of two alternative [123I]IBZM SPECT procedures. Eur J Nucl Med Mol Imaging. 2008 ; 35: 1350-1356
4. Boot E, Booij J, Zinkstok JR, et al. Striatal D2 receptor binding in 22q11 deletion syndrome: An [123I]IBZM SPECT study. J Psychopharmacol. 2010 ; 24: 1525-1531
5. Buckholtz JW, Treadway MT, Cowan RL, et al. Dopaminergic network differences in human impulsivity. Science. 2010 ; 329: 532
6. Davis JF, Choi DL, Schurdak JD, et al. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biol Psychiatry. 2011 ; 69: 668-674
7. De Weijer BA, van de Giessen E, van Amelsvoort TA, et al. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res. 2011 ; 1: 37
8. Dunn JP, Kessler RM, Feurer ID, et al. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care. 2012 ; 35: 1105-1111
9. Geiger BM, Haburcak M, Avena NM, et al. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience. 2009 ; 159: 1193-1199
10. Haltia LT, Rinne JO, Merisaari H, et al. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse. 2007 ; 61: 748-756
11. Jerlhag E, Egecioglu E, Dickson SL, et al. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict Biol. 2011 ; 16: 82-91
12. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010 ; 13: 635-641
13. Kegeles LS, Zea-Ponce Y, Abi-Dargham A, et al. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans. Synapse. 1999 ; 31: 302-308
14. Koob GF, Le MM. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001 ; 24: 97-129
15. Martinez D, Gil R, Slifstein M, et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry. 2005 ; 58: 779-786
16. Martinez D, Narendran R, Foltin RW, et al. Amphetamine-induced dopamine release: Markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry. 2007 ; 164: 622-629
17. Martinez D, Saccone PA, Liu F, et al. Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: Commonalities and differences with other types of addiction. Biol Psychiatry. 2012 ; 71: 192-198
18. Michaelides M, Thanos PK, Kim R, et al. PET imaging predicts future body weight and cocaine preference. Neuroimage. 2012 ; 59: 1508-1513
19. Morris JK, Bomhoff GL, Gorres BK, et al. Insulin resistance impairs nigrostriatal dopamine function. Exp Neurol. 2011 ; 231: 171-180
20. Munro CA, McCaul ME, Wong DF, et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry. 2006 ; 59: 966-974
21. Narayanaswami V, Thompson AC, Cassis LA, et al. Diet-induced obesity: Dopamine transporter function, impulsivity and motivation. Int J Obes (Lond). 2013 ; 37: 1095-1103
22. Narendran R, Martinez D. Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature. Synapse. 2008 ; 62: 851-869
23. Nijs IM, Franken IH, Muris P. The modified Trait and State Food-Cravings Questionnaires: Development and validation of a general index of food craving. Appetite. 2007 ; 49: 38-46
24. Pai MP, Paloucek FP. The origin of the 'ideal' body weight equations. Ann Pharmacother. 2000 ; 34: 1066-1069
25. Rinne JO, Hietala J, Ruotsalainen U, et al. Decrease in human striatal dopamine D2 receptor density with age: A PET study with [11C]raclopride. J Cereb Blood Flow Metab. 1993 ; 13: 310-314
26. Rothemund Y, Preuschhof C, Bohner G, et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. Neuroimage. 2007 ; 37: 410-421
27. Schiffer WK, Volkow ND, Fowler JS, et al. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse. 2006 ; 59: 243-251
28. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage. 2003 ; 19: 1709-1715
29. Stice E, Spoor S, Bohon C, et al. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science. 2008 ; 322: 449-452
30. Stice E, Spoor S, Ng J, et al. Relation of obesity to consummatory and anticipatory food reward. Physiol Behav. 2009 ; 97: 551-560
31. Stoeckel LE, Weller RE, Cook EW, et al. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. Neuroimage. 2008 ; 41: 636-647
32. Van de Giessen E, La Fleur SE, de Bruin CM, et al. Free-choice and no-choice high fat diets affect striatal dopamine D(2/3) receptor availability, caloric intake, and adiposity. Obesity. 2012 ; 20: 1738-1740
33. Van Kammen DP, Murphy DL. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia. 1975 ; 44: 215-224
34. Volkow ND, Wise RA. How can drug addiction help us understand obesity?. Nat Neurosci. 2005 ; 8: 555-560
35. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: Implications for obesity. Trends Cogn Sci. 2011 ; 15: 37-46
36. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997 ; 386: 830-833
37. Volkow ND, Wang GJ, Telang F, et al. Profound decreases in dopamine release in striatum in detoxified alcoholics: Possible orbitofrontal involvement. J Neurosci. 2007 ; 27: 12700-12706
38. Wang GJ, Geliebter A, Volkow ND, et al. Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity. 2011 ; 19: 1601-1608
39. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001 ; 357: 354-357
40. Wilcox CE, Braskie MN, Kluth JT, et al. Overeating behavior and striatal dopamine with 6-[F]-Fluoro-L-m-Tyrosine PET. J Obes. 2010 2010 ;:
41. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: How convincing is the addiction model?. Nat Rev Neurosci. 2012 ; 13: 279-286